• OPEN AN ACCOUNT
Indian Indices
Nifty
25,637.80 88.80
(0.35%)
Sensex
83,821.95 -236.95
( -0.28%)
Bank Nifty
57,443.90 237.20
( 0.41%)
Nifty IT
38,822.95 -173.30
( -0.44%)
Global Indices
Nasdaq
43,834.06 426.21
(0.98%)
Dow Jones
6,192.89 30.87
(0.50%)
Hang Seng
40,056.27 471.69
(1.19%)
Nikkei 225
8,798.91 63.31
(0.72%)
Forex
USD-INR
85.73 -0.26
(-0.30%)
EUR-INR
100.32 0.36
(0.36%)
GBP-INR
117.66 0.46
(0.39%)
JPY-INR
0.59 0.00
(0.31%)

EQUITY - MARKET SCREENER

Container Corporation Of India Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
531344
INE111A01025
202.6849127
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCOR
35.52
46074.84
EPS(TTM)
Face Value()
Div & Yield %
21.29
5
0.26
 

JB Chemicals receives USFDA approval for Amitriptyline Hydrochloride tablets
Jun 25,2025
The approved dosages—10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg—are indicated for the treatment of symptoms of depression. Amitriptyline Hydrochloride is a tricyclic antidepressant widely prescribed for managing major depressive disorders.

JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radio-diagnostics, APIs, and intermediates.

The company's consolidated net profit rose 15.5% to Rs 145.69 crore on a 10.2% rise in revenue to Rs 949.48 crore in Q4 FY25, compared with Q4 FY24.

Shares of JB Chemicals & Pharmaceuticals rose 0.10% to Rs 1,800.60 on the BSE.